Wang Xianfeng, Mao Yicheng, Xu Hanlu, Chen Jiyang, Chen Xiao
Department of Orthopedics, Suzhou Hospital of Anhui Medical University, Suzhou, 234000, Anhui, China.
Wenzhou Medical University, Wenzhou, 325000, Wenzhou, China.
Heliyon. 2023 Sep 1;9(9):e19680. doi: 10.1016/j.heliyon.2023.e19680. eCollection 2023 Sep.
The epigenetic regulator in cancer progression and immune response has been demonstrated recently. However, the potential implications of 5-methylcytosine (mC) in soft tissue sarcoma (STS) are unclear.
The RNA sequence profile of 911 normal and 259 primary STS tissues were obtained from GTEx and TCGA databases, respectively. We systematically analyzed the mC modification patterns of STS samples based on 11 mC regulators, and comprehensively correlated these modification patterns with clinical characteristics, prognosis, and tumor microenvironment (TME) cell-infiltrating. Furthermore, an mC-related signature was generated using Cox proportional hazard model and validated by the GSE17118 cohort.
Two distinct mC modification patterns (cluster1/2) were discovered. The cluster1 had favorable overall survival, higher immune score, higher expression of most immune checkpoints, and active immune cell infiltration. The GSVA analysis of the P53 pathway, Wnt signaling pathway, G2M checkpoint, mTORC1 signaling, Wnt/β catenin signaling, and PI3K/AKT/mTOR signaling were significantly enriched in the cluster2. Moreover, 1220 genes were differentially expressed between two clusters, and a mC prognostic signature was constructed with five mC-related genes. The signature represented an independent prognostic factor and showed the favorable performance in the GSE17118 cohort. Patients in the low-risk group showed higher immunoscore and higher expression of most immune checkpoints. Further GSVA analysis indicated that the levels of P53 pathway, Wnt signaling pathway, and TGF-β signaling pathway were different between low- and high-risk groups. Moreover, a nomogram incorporating mC signature and clinical variables was established and showed well performance.
This work showed that the mC modification plays a significant role in the progression of STS and the formation of TME diversity. Evaluating the mC modification pattern of tumor will enhance our cognition of TME infiltration characterization to guide more effective immunotherapy strategies.
表观遗传调节因子在癌症进展和免疫反应中的作用最近已得到证实。然而,5-甲基胞嘧啶(mC)在软组织肉瘤(STS)中的潜在影响尚不清楚。
分别从GTEx和TCGA数据库中获取911个正常组织和259个原发性STS组织的RNA序列谱。我们基于11个mC调节因子系统地分析了STS样本的mC修饰模式,并将这些修饰模式与临床特征、预后和肿瘤微环境(TME)细胞浸润进行了全面关联。此外,使用Cox比例风险模型生成了一个mC相关特征,并通过GSE17118队列进行了验证。
发现了两种不同的mC修饰模式(簇1/2)。簇1具有良好的总生存期、较高的免疫评分、大多数免疫检查点的高表达以及活跃的免疫细胞浸润。P53途径、Wnt信号通路、G2M检查点、mTORC1信号传导、Wnt/β连环蛋白信号传导和PI3K/AKT/mTOR信号传导的GSVA分析在簇2中显著富集。此外,两个簇之间有1220个基因差异表达,并使用五个与mC相关的基因构建了一个mC预后特征。该特征代表了一个独立的预后因素,并在GSE17118队列中表现良好。低风险组患者显示出更高的免疫评分和大多数免疫检查点的更高表达。进一步的GSVA分析表明,低风险组和高风险组之间P53途径、Wnt信号通路和TGF-β信号通路的水平不同。此外,建立了一个纳入mC特征和临床变量的列线图,表现良好。
这项工作表明,mC修饰在STS的进展和TME多样性的形成中起重要作用。评估肿瘤的mC修饰模式将增强我们对TME浸润特征的认识,以指导更有效的免疫治疗策略。